9National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing [S]. Approved standard M100-S14. Wayne, Pennsylvania: NCCLS, 2004.48-65.
10Leal-Noval SR, Marquez-Vacaro JA, Garcia Curiel A, et al. Nosocomial pneumonia in patients undergoing heart surgery [J]. Crit Care Meal,2000,28:935-940.
4Gales AC,Jones RN,Forward KR,et al.Emerging importance of multi-drug-resistant Acinetobacter species and Stenotrophomonas malto-philiaas pathogens in seriously ill patients:geographic patterns,epide-miological features,and trends in the SENTRY Antimicrobial Surveil-lance Program(1997-1999)[J].Clin Infect Dis,2001,32(Sup-pl 2):104-113.
5NNIS System.National Nosocomial Infections Surveillance(NNIS)Sys-tem Report,data summary from January 1992 through June 2003,is-sued August 2003[J].Am J Infect Control,2003,31(8):481-498.
6Costa SF,Woodcock J,Gill M,et al.Outer-membrane proteins pat-tern and detection of beta-lactamase in clinical isolates of imipenem-resistant Acinelobacter baumannii from Brazil[J].Int J AntimicrobAgents,2000,13(3):175-182.
7Limansky AS,Mussi MA,Viale AM,et al.Loss of a 29-kilodaltonouter membrane protein in Acinelobacter baumannii is associated withimipenem resistance[J].J Clin Microbiol,2002,40(12):4776-4778.
8Fernandez-Cuenca F,Martinez-Martinez L,Conejo MC,et al.Rela-tionship betweenβ-lactamase-production,outermembrane proteinand penicillin-binding protein profiles on the activity of carbapenems a-gainst clinical isolates of Acinelobacter baumannii[J].J AntimicrobChemother,2003,51(3):565-574.
